Karen O. Klein, MD, and Kent L. Reifschneider, MD, discuss a central precocious puberty (CPP) patient case regarding factors that would lead a physician to either stop treating a patient or continue with treatment.
Kent L. Reifschneider, MD
Advertisement
Articles by Kent L. Reifschneider, MD
Karen O. Klein, MD, and Kent L. Reifschneider, MD, discuss a central precocious puberty (CPP) patient case regarding factors that would lead a physician to treat a patient.
Karen O. Klein, MD, and Kent L. Reifschneider, MD, discuss individualizing treatment decisions in girls with central precocious puberty (CPP).
Advertisement
Latest Updated Articles
CPP Patient Case: When to Stop TreatmentPublished: April 25th 2022 | Updated:
Individualizing Treatment Decisions in Girls With Central Precocious PubertyPublished: April 25th 2022 | Updated:
CPP Patient Case: When to TreatPublished: April 25th 2022 | Updated:
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FDA approves aflibercept injection 8 mg to treat macular edema and monthly dosing
2
Early genetic testing may reshape care for inherited connective tissue disorders in children
3
Alice Hoyt, MD, discusses the importance of quick epinephrine use for anaphylaxis
4
Roflumilast Efficacy and Safety in Pediatric AD
5
